Aslan Pharmaceuticals Ltd ADR (ASLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASLN | ATNF | BDRX | ||
| Company | Aslan Pharmaceuticals Ltd ADR | 180 Life Sciences Corp | Biodexa Pharmaceuticals Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.6300 | 1.8900 | 3.95 | ||
| High | 0.7000 | 1.8984 | 3.95 | ||
| Low | 0.6000 | 1.7900 | 3.80 | ||
| Last | 0.6000 | 1.8984 | 3.95 | ||
| Change | -0.0999 | +0.0384 | -0.04 | ||
| % Change | -14.27% | +2.06% | -1.00% | ||
| Volume | 806,300 | 26,742 | 15,253 | ||
| 20-Day Average Volume | 289,117 | 127,757 | 81,283 | ||
| Previous Close | 0.6999 | 1.8600 | 3.99 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.0725 | 2.0679 | 4.74 | ||
| 20-Day Raw Stochastic | 5.23% | 19.21% | 2.36% | ||
| 20-Day Relative Strength | 25.90% | 42.25% | 38.20% | ||
| Weighted Alpha | -93.79 | -88.26 | -93.01 | ||
| Today's Opinion | 100% Sell | 40% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 40% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Sell | 16% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -75.71% since 07/11/24 | +4.31% since 12/16/24 | -6.39% since 12/16/24 | ||
| Low | 0.4750 on 07/17/24 | 1.6900 on 12/17/24 | 3.80 on 12/23/24 | ||
| High | 2.7314 on 07/12/24 | 2.0200 on 12/20/24 | 4.39 on 12/17/24 | ||
| 1-Month | |||||
| %Chg | -75.97% since 06/18/24 | -15.63% since 11/22/24 | -14.99% since 11/22/24 | ||
| Low | 0.4750 on 07/17/24 | 1.6900 on 12/17/24 | 3.80 on 12/23/24 | ||
| High | 2.8640 on 06/21/24 | 2.7750 on 12/02/24 | 7.40 on 12/03/24 | ||
| 3-Month | |||||
| %Chg | -86.11% since 04/18/24 | +2.06% since 09/23/24 | -43.24% since 09/23/24 | ||
| Low | 0.4750 on 07/17/24 | 1.1600 on 10/08/24 | 3.50 on 11/19/24 | ||
| High | 4.8968 on 04/22/24 | 17.7500 on 10/16/24 | 10.89 on 10/16/24 | ||
| 6-Month | |||||
| %Chg | -85.84% since 01/18/24 | +30.03% since 06/21/24 | -85.34% since 06/21/24 | ||
| Low | 0.4750 on 07/17/24 | 1.1600 on 10/08/24 | 3.50 on 11/19/24 | ||
| High | 16.7200 on 03/12/24 | 17.7500 on 10/16/24 | 41.50 on 07/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,226 | 1,910 | 475 | ||
| Shares Outstanding, K | 2,044 | 1,027 | 119 | ||
| Annual Sales | 12,000,000 | 0 | 410,000 | ||
| Annual Net Income | -44,220,000 | -19,940,000 | -7,660,000 | ||
| Last Quarter Sales | 0 | 0 | N/A | ||
| Last Quarter Net Income | -9,920,000 | -840,000 | N/A | ||
| 60-Month Beta | 1.40 | 0.12 | 1.45 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -10.32 on 05/09/24 | -0.85 on 11/14/24 | N/A | ||
| Latest Earnings Date | 08/09/24 | 11/14/24 | 04/26/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||